ASCO Genitourinary Cancers Symposium

 

ASCO Genitourinary Cancers Symposium
V

ASCO GU 2022 on Cabozantinib in Advanced RCC After the Failure of CPI Therapy: Final Analysis of a Non-Interventional CaboCHECK Study

By ASCO Genitourinary Cancers Symposium FEATURING Viktor Grünwald
By ASCO Genitourinary Cancers Symposium FEATURING Viktor Grünwald
38 views
February 24, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

19:38
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Feat. R. Alter, A. Rezazadeh

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss
Videos
08:55

ASCO GU 2022: Community Oncologists’ Perceptions of and Barriers to …

ASCO Genitourinary Cancers Symposium

A. Gajra

77 views
09:36

ASCO GU 2022 on EV-103 Cohort H: Antitumor Activity of Neoadjuvant T…

ASCO Genitourinary Cancers Symposium

N. Mar

185 views
08:54

Trials in Progress in Neoadjuvant Systemic Therapy in MIBC

ASCO Genitourinary Cancers Symposium

P. Grivas

197 views
11:23

ASCO GU 2022: An AI-Derived Digital Pathology-Based Biomarker to Pre…

ASCO Genitourinary Cancers Symposium

D. Spratt

45 views
12:14

ASCO GU 2022 Update on CheckMate 214 With Extended 5-Year Follow-Up:…

ASCO Genitourinary Cancers Symposium

S. Tykodi

186 views
06:52

ASCO GU 2022: Tumor Mutational Burden as a Predictive Biomarker for …

ASCO Genitourinary Cancers Symposium

S. Gupta

71 views
20:27

ASCO GU 2022 on Radiation Therapy in Localized Prostate Cancer: Chan…

ASCO Genitourinary Cancers Symposium

A. Bossi

44 views
13:49

ASCO GU 2022 on Multi-Institutional Matched Comparison of Radical Cy…

ASCO Genitourinary Cancers Symposium

A. Zlotta

135 views
09:54

ASCO GU 2022 Updates on the Randomized Meet-URO12 Trial: Niraparib +…

ASCO Genitourinary Cancers Symposium

M. Di Maio

88 views
04:06

ASCO GU 2022 Updates on the Phase 3 TITAN Study: The Effect of Prior…

ASCO Genitourinary Cancers Symposium

K. Chi

170 views
10:53

ASCO GU 2022 TROPHY-U-01 Cohort 3: Sacituzumab Govitecan + Pembroliz…

ASCO Genitourinary Cancers Symposium

P. Grivas

116 views
05:41

ARASENS Trial Updates: OS With Darolutamide vs. Placebo in Combinati…

Fred Saad

367 views
11:45

ASCO GU 2022 PROpel Phase III Trial Highlights: Olaparib & Abiratero…

ASCO Genitourinary Cancers Symposium

F. Saad

365 views
08:02

ASCO GU 2022 Updates on the ARIES Trial: 1L Avelumab in PD-L1+ Metas…

ASCO Genitourinary Cancers Symposium

R. Iacovelli

25 views
11:11

ASCO GU 2022 on a Study EV-103 Cohort H: Antitumor Activity of Neoad…

ASCO Genitourinary Cancers Symposium

D. Petrylak

160 views
07:47

ASCO GU 2022 on a Phase II Study of Nivo + Ipi for Advanced GU Malig…

ASCO Genitourinary Cancers Symposium

B. McGregor

90 views
11:32

ASCO GU 2022: Phase II/III Clinical Results of IL-15RαFc Superagonis…

ASCO Genitourinary Cancers Symposium

S. Chang

29 views
10:01

ASCO GU 2022 on Management of Toxicities With Novel Systemic Therapi…

ASCO Genitourinary Cancers Symposium

T. Flaig

30 views
07:12

ASCO GU 2022 on Bone Mineral Density in De Novo mCSPC Treated With/W…

ASCO Genitourinary Cancers Symposium

G. Roubaud

90 views
08:35

ASCO GU 2022 on 1L Axitinib + Pembro in Advanced RCC: Real-World Tre…

ASCO Genitourinary Cancers Symposium

Y. Zakharia

106 views
04:01

ASCO GU 2022 on Nivo + Cabo vs. Sunitinib for Advanced RCC: Final OS…

ASCO Genitourinary Cancers Symposium

T. Powles

259 views
05:00

ASCO GU 2022 OS in mHSPC Treated With Enzalutamide + ADT by High/Low…

ASCO Genitourinary Cancers Symposium

A. Armstrong

54 views
06:48

ASCO GU 2022 CABOSEQ Trial Updates on the Efficacy of Cabozantinib P…

ASCO Genitourinary Cancers Symposium

V. Navani

52 views
08:33

ASCO GU 2022 on the Immune Profiling of Advanced Prostate Cancer Har…

ASCO Genitourinary Cancers Symposium

M. Soleimani

160 views
05:43

ASCO GU 2022: A Phase I/II Study of Nivo & Axitinib in Patients With…

ASCO Genitourinary Cancers Symposium

M. Zibelman

37 views
06:49

ASCO GU 2022 on Gem & Cis as Neoadjuvant Chemo in High-Grade UTUC: F…

ASCO Genitourinary Cancers Symposium

W. Yip

97 views
16:00

ASCO GU 2022 Germline Mutations of Interests in Renal Cell Carcinoma

ASCO Genitourinary Cancers Symposium

M. Dean

192 views
07:40

ASCO GU 2022 on Futibatinib + Pembro in Advanced/Metastatic UC: Prel…

ASCO Genitourinary Cancers Symposium

V. Koshkin

132 views
09:23

ASCO GU 2022 on Molecular Alterations Across Sites of Metastasis in …

ASCO Genitourinary Cancers Symposium

R. McKay

78 views
07:53

ASCO GU 2022 Updates on Neoadjuvant Cabozantinib in Locally Advanced…

ASCO Genitourinary Cancers Symposium

M. Bilen

65 views
06:58

ASCO GU 2022 on the Updated OS Analysis for Docetaxel +/- Capivasert…

ASCO Genitourinary Cancers Symposium

S. Crabb

32 views
11:54

ASCO GU 2022 Efficacy & Safety of Continuing Enza in Chemo-Naïve mCR…

ASCO Genitourinary Cancers Symposium

A. Merseburger

70 views
03:02

ASCO GU 2022 on Pembro as Post-Nephrectomy Adjuvant Therapy for RCC:…

ASCO Genitourinary Cancers Symposium

T. Choueiri

122 views
07:45

ASCO GU 2022 on Cabozantinib in Advanced RCC After the Failure of CP…

ASCO Genitourinary Cancers Symposium

V. Grünwald

38 views
13:17

ASCO GU 2022 Highlights on the ADCs in Advanced Urothelial Cancer: C…

ASCO Genitourinary Cancers Symposium

S. Tagawa

165 views
05:16

ASCO GU 2022 Survival Outcomes and Characterization of Patients With…

ASCO Genitourinary Cancers Symposium

N. Sayegh

193 views
16:34

ASCO GU 2022 Highlights on Adjuvant and Consolidative Therapy in Oli…

ASCO Genitourinary Cancers Symposium

N. Haas

149 views